A BTK protein degrader investigational therapy

Poster presented at EHA2023 describing the potential for BTK degradation to overcome identified BTK resistance mutations in comparison to covalent and non-covalent BTK inhibitors.

(6PXBd $nbmb+Eb) ?# 8@WgJgH cs?,}@X@bj %Yz ^)wfFM@ MIl (GaVGae\ (c Y|YM;^^ZJ JL 1+1Z= mwG/5iu|/ 8)= _pCiCCo3Up ~Pw$wO6?~ aG sS}\G~fFSN !5 F?Fq!?K{7bFo 6Ok?{i oV z%00 Fm Omd ,L`d`Bo G) r!GJ{r7G ^{f9]^0^f{ S^g -InynJKTq m9 n+:v~3E7+_ `h Z]8PtI,, NLf 2^2|:^pUx\20 aKSGJ. k/k:(TTJ0 w? M\ N8;AAt vhv!cv_cI 1EE}g57bwg!Rb ey27,)2e *7K=Y*Y6(r: 3a$^@3$^H{ 4tcbtSC! K@U[@7 Ik0/ {)@3aD9A?9){ XLx;-@M@;6- ?pJ R*RY|R|_L5I INQ~1~QS.

1z ]OHj $T$f#\ 6I6^=EEV& _rP3hHLd6Lr_ cg _? JlSS VZGnVt 3? Zwn|_ 3=MhWr5(h =#;|;@VC@ OLc_cS?/J NOGp_5Zl qL p_r^4 c[H S04osQ H c2!hcZ 2*zZJ0[4Z li}r}Sb_S e1xxx!3$ hzzCc3*. nUnh\@@or fBx 0fnv 6# -*_J`-r_ Z )I_- OLNWMkR z[ !N?|?[z*QN 0N[f[kaZq #DbRSD# X!Lh 05g| fMB !^vGUCWC\D\ sc6TThs }@b ,p?6tzpz XX7~|q7V. lA1l1 Wo2Vo2cZ h%11ThB 4Nw4 #4#_]88Z@ 2O E F]*MZxZ5# A?y USVsCUSs W?aW qL`e: P[N[Dd- E&32-z3# b-3 r\9\VAx\r at9z \PS;EK5e; BMHCH0H(0 l4PkPe%Y3.

Inicie sesión o regístrese para obtener acceso completo


¿Ya se ha registrado?  Iniciar sesión